Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

FBIO Fortress Biotech, Inc.
$1.93 3.21% +0.06
Notify me if price changes either direction
Interactive Brokers Logotype

Buy FBIO stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Fortress Biotech, Inc. (FBIO)

Loading

Key Stats

Market cap. 62.4M
Enterprise value -38944644
Trailing PE 0.67753625
Forward PE -1.0625
PEG Ratio -0.0058408297413793
Enterprise to EBITDA 1.559
Enterprise to revenue -0.569
Price to book MRQ 0.3795413
Price to sales TTM 0.9109099

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 68.5M
EBITDA -24979000
Diluted EPS TTM 2.76
Total Cash (MRQ) 196.6M
Current ratio (MRQ) 3.959
Operating Cash Flow (TTM) 125.9M

FBIO trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent FBIO News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.